Enzymatic Therapy
This article was originally published in The Tan Sheet
Executive Summary
North Castle Partners acquires a "substantial equity investment" in the dietary supplement firm, buying part of the company from Enzymatic founder and President Terry Lemerond. A significant ownership share will be retained by Lemerond, and he will serve on the board of directors and as vice chairman. No new president has been named. The company says it will continue to market its products in health food channels and will not turn to mass market
|
North Castle Partners acquires a "substantial equity investment" in the dietary supplement firm, buying part of the company from Enzymatic founder and President Terry Lemerond. A significant ownership share will be retained by Lemerond, and he will serve on the board of directors and as vice chairman. No new president has been named. The company says it will continue to market its products in health food channels and will not turn to mass market. |